Heart transplantation associated arrhythmias

Jump to navigation Jump to search


Heart transplantation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Complications and Prognosis

Diagnosis

Indications

Evaluation

Contraindications

Criteria for Cardiac Transplantation

Equitable Distribution of Donor Hearts to those Awaiting Transplantation and the Process of Being Listed for a Transplant

Treatment

Medical Therapy

Surgery

Follow-Up

Electrocardiogram and Pacing After Cardiac Transplantation

Heart transplantation associated arrhythmias On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heart transplantation associated arrhythmias

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Heart transplantation associated arrhythmias

CDC onHeart transplantation associated arrhythmias

Heart transplantation associated arrhythmias in the news

Blogs on Heart transplantation associated arrhythmias

Directions to Hospitals Treating Heart transplantation

Risk calculators and risk factors for Heart transplantation associated arrhythmias

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

Types of Arrhythmias Occurrence Common mechanism Treatment
Tachyarrhythmias Supra-ventricular tachy- arrthymia

(SVT)

Atrial fibrillation Common in early postoperative period
Over all frequency 47.3%

(Elkaryoni et al.)

1. Graft manipulation (primary graft failure) 1. Evaluate and manage the trigger

2. Persistent cases: Catheter ablation

2. Inflammatory changes (pericardial inflammation)
3. Autonomic hypersensitivity  
4. Ischemia
5. Denervation
6. Early rejection
7. Inotrpes
Atrial flutter Common in immediate  postoperative period (>1 month)
Over all frequency 7.6%

(Elkaryoni et al.)

1. AR - 28% cases

2. Remodelling of atria (late onset ) 3. Atrial suture lines - conduction barriers 4. Recipient to donor atrial conduction 5. Increased risk with bi-atrial method 6. Increased risk with older donor age

1. Evaluate and manage the trigger

2. Persistent cases: Radiofrequency ablation

Other SVTs Focal atrial tachycardia Formation of depolarization foci near the atrial scar that take control of the heart rhythm. Foci can be found in donor atrium or in the atrial remnant of recipient which passes into the donor. Focal catheter ablation
Atrial reenterant tachycardia & Nodal reenterant tachycardia Requires a preexisting route in the donor that allows a macroreentrant. Radiofrequency ablation (RFA)
Atrial macro-reentrant tachycardia site of origin is mostly in the upper right atrium, around the native and donor suture line Radiofrequency ablation (RFA)
Recipient-to-donor atrial conduction tachycardia site of origin usually right atrial anastomosis. Radiofrequency ablation (RFA)
Ventricular tachycardias
Over all frequency 7.6%

(Elkaryoni et al.)

Non-sustained Early post-transplat period 1.Acute rejection

2. Graft vasculopathy 3. Severe cardiac allograft vasculopathy (in symptomatic cases)

ICD placement (in symptomatic cases)
Sustained Early post-transplat period 1. Acute rejection (if presenting during immediate post operative period)

2. Allopathic vasculopathy 3. LV dysfunction

Prompt for coronary angiography and cardiac biopsy
Ventricular fibrillation 1.1% Transplant coronary artery disease
Bradyarrhytmia Sick sinus syndrome (SSS) 0.5  %

(Elkaryoni et al.)

1. Sympathetic denervation

2. Ischemic injury to the sinus node 3. Graft ischemia or rejection 4. Drug effects  

Sudden cardiac arrrest 3.7%

(Elkaryoni et al.)

1. SSS

2. Cardiac allograft vasculopathy 3. Transplant coronary artery disease

Heart Block 0.3%

(Elkaryoni et al.)

1. Postoperative injury

2. Progressive conduction system disease associated with coronary artery disease 3. LV dysfunction 4. Chronic rejection 5. Injury from endomyocardial biopsies.

  • Post heart transplant Arrhythmias can be divided into tachyarrhythmias (heart rate > 100/min)  and bradyarrhythmia (heart rate < 60 /min). Tachycardias are further classified based on place of origin, such as supraventricular arrhythmias originate between sinus node and the AV node, where as ventricular arrhythmias originate below the AV node at the ventricular level.

Tachyarrhythmias

  • Supraventricular tachyarrhythmias (SVT)

It includes-

  • Atrial Premature Complexes (benign)
  • Atrial Fibrillation
  • Atrial Flutter
  • Supraventricular Tachycardias like AV Reentrant Tachycardias
  • Atrial Fibrillation is the most common and mostly occur in the early postoperative period. [1]
      • Mechanism:
        • Early postoperative period: associated with pericardial inflammation, graft manipulation, primary graft failure, allograft rejection (AR) (37.5%), and autonomic changes(such as due to denervation), ischemia, and inotropes.[2]
        • Postoperative period (> 1 month): seen to be associated with allograft vasculopathy (in 21% cases), rejection (in 46% cases) or infection.[3]
      • Occurrence:
        • In relation to technique of heart transplantation: meta-analysis reports pooled estimated incidence of AF:[4]
          1. Biatrial technique: 18.7% (95%CI: 10.3%-31.5%)
          2. Bicaval technique: 11.1% (95%CI: 6.5%-18.4%)
        • Frequency in relation to timing of onset postoperative period:
          • POAF (</= 1 month): 6.2%
          • POAF (> 1 month): 4%

Pathophysiology

Risk Factors

  • Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Treatment

Medical Therapy

  • There is no treatment for [disease name]; the mainstay of therapy is supportive care.
  • The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
  • [Medical therapy 1] acts by [mechanism of action 1].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

  • Surgery is the mainstay of therapy for [disease name].
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
  • [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

  • There are no primary preventive measures available for [disease name].


References

  1. Creswell, Lawrence L.; Schuessler, Richard B.; Rosenbloom, Michael; Cox, James L. (1993). "Hazards of postoperative atrial arrhythmias". The Annals of Thoracic Surgery. 56 (3): 539–549. doi:10.1016/0003-4975(93)90894-N. ISSN 0003-4975.
  2. Thajudeen, Anees; Stecker, Eric C.; Shehata, Michael; Patel, Jignesh; Wang, Xunzhang; McAnulty, John H.; Kobashigawa, Jon; Chugh, Sumeet S. (2012). "Arrhythmias After Heart Transplantation: Mechanisms and Management". Journal of the American Heart Association. 1 (2). doi:10.1161/JAHA.112.001461. ISSN 2047-9980.
  3. Boyle, Noel G; Shivkumar, Kalyanam; Vaseghi, Marmar; Taleski, Jane; Hamon, David (2014). "Arrhythmias in the Heart Transplant Patient". Arrhythmia & Electrophysiology Review. 3 (3): 149. doi:10.15420/aer.2014.3.3.149. ISSN 2050-3377.
  4. Chokesuwattanaskul, Ronpichai; Bathini, Tarun; Thongprayoon, Charat; Preechawat, Somchai; O'Corragain, Oisin A.; Pachariyanon, Pavida; Ungprasert, Patompong; Cheungpasitporn, Wisit (2018). "Atrial fibrillation following heart transplantation: A systematic review and meta-analysis of observational studies". Journal of Evidence-Based Medicine. 11 (4): 261–271. doi:10.1111/jebm.12323. ISSN 1756-5391.

Template:WS Template:WH